Vivodyne: Funding, Investors & Team (Aug 2026)
Vivodyne expedites the process of finding remedies for human diseases by conducting large-scale drug tests on lab-created three-dimensional human tissues.
Vivodyne has raised $38.0M across 1 funding round on record, the most recent a Seed of $38.0M announced in Nov 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vivodyne Company Profile and Key Stats
Latest funding round on record: Nov 2023.
Vivodyne Funding Rounds
Vivodyne Founders and Leadership Team
No contact details are on record for this team yet.
Vivodyne Funding Compared to Other Biotechnology Startups
Vivodyne's latest round of $38.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vivodyne in Biotechnology and Philadelphia
Companies Similar to Vivodyne
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Vivodyne Funding FAQs
What does Vivodyne do?
Vivodyne expedites the process of finding remedies for human diseases by conducting large-scale drug tests on lab-created three-dimensional human tissues.
How much funding has Vivodyne raised?
Vivodyne has raised $38.0M across 1 round on record. The most recent is a Seed of $38.0M announced in Nov 2023.
When did Vivodyne last raise funding?
Vivodyne's most recent funding round on record is a Seed of $38.0M, announced in Nov 2023.
Who is the CEO of Vivodyne?
Andrei Georgescu is listed as CEO at Vivodyne.
Where is Vivodyne headquartered?
Vivodyne is based in Philadelphia, Pennsylvania, United States.
How many employees does Vivodyne have?
Vivodyne is in the 11-50 employee band.
How does Vivodyne's funding compare to other Biotechnology startups?
Vivodyne's latest round of $38.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Vivodyne Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vivodyne is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.